This finding was in concurrence with the in vitro data obtained from ovarian cancer cell lines, which showed that expression of both SGK-1 and MKP-1 was rapidly induced by activation of the GR and could be reversed through GR blockade. Here, NR3C1 is linked to ovarian carcinoma.